Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

13 May 2008 11:03

RNS Number : 3094U
UBS AG (EPT)
13 May 2008
Β 

ο»Ώ

FORM 38.5(b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERSΒ 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

Β 

Β 

1. KEY INFORMATION

Β 

Name of exempt principal trader

UBS AGΒ LondonΒ Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relateΒ (Note 1)

10p Ordinary

Date of dealing

12Β MAY 2008

Β 

Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a) Interests and short positions (following dealing) in the class ofΒ 

relevant security dealt inΒ (Note 2)

Β 

Β 

Long

Β 

Short

Β 

Β 

Number

(%)

NumberΒ 

(%)

(1) Relevant securitiesΒ 

468,152

0.42%

191

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

468,152

0.42%

191

0.00%

(b) Interests and short positions in relevant securities of

the company, other than the class dealt in (NoteΒ 2)

Β 

Class of relevant security:

Long

Β 

Short

Β 

Β 

NumberΒ 

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

Rights to subscribeΒ (Note 2)

Class of relevant security:

Details

3. DEALINGSΒ (Note 3)

Β (a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 4)

SALE

300

1517Β pence

PURCHASE

166

1518

SALE

2292

1518

SALE

724

1518

SALE

324

1518

SALE

1000

1518

SALE

166

1518

SALE

4940

1518

PURCHASE

166

1518

SALE

361

1518

SALE

189

1518

SALE

166

1518

SALE

188

1518

SALE

300

1518

SALE

400

1518

PURCHASE

4937

1519

SALE

4937

1519

PURCHASE

1492

1519

PURCHASE

529

1519

SALE

108

1519

SALE

700

1519

SALE

400

1519

SALE

500

1519

SALE

400

1519

SALE

300

1519

SALE

1500

1519

SALE

500

1520

PURCHASE

788

1520

PURCHASE

44

1520

PURCHASE

859

1520

PURCHASE

1753

1520

PURCHASE

2852

1520

PURCHASE

329

1520

SALE

400

1520

SALE

626

1520

SALE

400

1520

SALE

300

1520

PURCHASE

158

1520

PURCHASE

1400

1520

SALE

48

1521

SALE

100

1521

SALE

421

1521

SALE

100

1521

SALE

6

1521

SALE

233

1521

PURCHASE

4896

1521

PURCHASE

1110

1521

PURCHASE

638

1521

PURCHASE

46

1521

PURCHASE

1046

1521

PURCHASE

164

1521

PURCHASE

4927

1522

SALE

1000

1522

PURCHASE

691

1522

SALE

548

1523

PURCHASE

146

1523

SALE

140

1524

SALE

2000

1524

SALE

140

1524

SALE

100

1524

SALE

50

1524

SALE

100

1524

SALE

421

1524

SALE

200

1524

SALE

2

1524

PURCHASE

300

1524

SALE

189

1527

SALE

132

1528

SALE

89

1528

SALE

793

1528

(b) Derivatives transactions (other than options)

Product name, e.g CFD

Long/shortΒ (Note 5)

Number of securitiesΒ (Note 6)

Price per unitΒ (Note 4)

Β 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product name,e.g. call option

Writing, selling, purchasing, varying etc

Number of securities to which the option relatesΒ (Note 6)

Exercise priceΒ 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unitΒ (Note 4)

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securitiesΒ 

Exercise price per unit (Note 4)

Β 

(d) Other dealings (including new securities)Β (Note 3)

Β 

Nature of transaction(Note 7)

Details

Price per unit (if applicable)

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

……………………………………………………………………

Β 

……………………………………………………………………

Β 

Is a Supplemental Form 38.5(b) attached?Β (Note 8) NO

Β 

Date of disclosure

12 MAY 2008

Contact name

NIMISHA SACHDEV

Telephone number

020 7567 8762

Name of offeree/offeror with which connected

Halliburton Company

Nature of connection (Note 9)

CONNECTED ADVISER

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
EMMBGGDURUBGGIX
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of AGM
2nd Jun 20267:00 amRNSFinal Results
7th Jan 20267:00 amRNSTrading Update
30th Sep 20257:00 amRNSUnaudited Interim Results
30th Jun 20257:00 amRNSResult of AGM - Replacement
26th Jun 202511:44 amRNSResult of AGM
3rd Jun 20253:00 pmRNSNotice of AGM & Posting of Annual Report
3rd Jun 20257:00 amRNSFinal Results
2nd May 20259:58 amRNSNotice of Results
3rd Apr 20257:00 amRNS-RASU+GSV Summit, Launch of Titanic VR & ENGAGE 4.0
10th Feb 20257:00 amRNS-RENGAGE XR attending Leap 2025 with PwC Middle East
22nd Jan 20257:00 amRNS-RLaunch of Education Offering at Bett 2025
6th Jan 20257:00 amRNSPre-Close Trading Update
26th Sep 20243:51 pmRNSHolding(s) in Company
26th Sep 20243:50 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSUnaudited Interim Results
9th Aug 20247:00 amRNSAppointment of Sole Broker
6th Aug 20247:00 amRNSPre-Close Trading Update and Notice of Results
30th Jul 20245:32 pmRNSHolding(s) in Company
10th Jul 20248:59 amRNSHolding(s) in Company
27th Jun 20244:11 pmRNSHolding(s) in Company
27th Jun 20243:35 pmRNSResult of AGM
28th May 20247:22 amRNSNotice of AGM & Posting of Annual Report
28th May 20247:00 amRNSBoard and Committee Changes
23rd Apr 202412:53 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSFinal Results
28th Mar 20247:00 amRNSNotice of Results & Investor Presentation
13th Mar 20247:00 amRNSLaunch of School of AI
26th Feb 20247:00 amRNSTrading Update
23rd Feb 20247:00 amRNSHolding(s) in Company
20th Feb 20247:00 amRNSMajor Contract Wins
19th Dec 20237:00 amRNSTrading Update
8th Dec 20237:00 amRNSBoard Change
11th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSNotice of Investor Presentation
3rd Aug 20237:00 amRNSGrant of Options
1st Aug 20237:00 amRNSPre-Close Trading Update and Notice of Results
29th Jun 20232:23 pmRNSResult of AGM
7th Jun 20237:00 amRNSNotice of AGM
1st Jun 20237:00 amRNSLaunch of Lenovo’s new VR headset
23rd May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSInvestor Presentation
27th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSFatboy Slim concert takes place in ENGAGE Link
21st Mar 20237:00 amRNSCancellation of Admission to Euronext Growth
17th Mar 20237:00 amRNSFatboy Slim set to perform in ENGAGE
8th Mar 20231:05 pmRNSTR-1: Notification of major holdings
7th Mar 20235:30 pmRNSTR-1: Notification of major holdings
7th Mar 20232:19 pmRNSTR-1: Notification of major holdings
6th Mar 20234:50 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.